ISO 18330:2003
(Main)Milk and milk products — Guidelines for the standardized description of immunoassays or receptor assays for the detection of antimicrobial residues
Milk and milk products — Guidelines for the standardized description of immunoassays or receptor assays for the detection of antimicrobial residues
ISO 18330|IDF 188:2003 gives guidelines for the standardized description of immunoassays or receptor assays for the detection of antimicrobial residues in milk and milk products. It is intended to provide a framework and basis for the evaluation/validation of tests based on the binding of an antimicrobial compound to its specific antibody or to other types of detecting molecules. In addition to immunoassays [e.g. enzyme-immunoassay (EIA) and radio-immunoassay (RIA)], there are several quantitative, semi-quantitative and qualitative test formats based on the binding of antimicrobial compounds to microbial receptors or to receptor proteins. Enzymatic assays and particle-based assays based on receptor proteins are referred to as receptor assays in ISO 18330|IDF 188:2003.
Laits et produits laitiers — Lignes directrices pour la description normalisée des essais immunologiques et des essais récepteur pour la détection des résidus antimicrobiens
General Information
Relations
Standards Content (Sample)
INTERNATIONAL ISO
STANDARD 18330
IDF
188
First edition
2003-09-01
Milk and milk products — Guidelines for
the standardized description of
immunoassays or receptor assays for the
detection of antimicrobial residues
Laits et produits laitiers — Lignes directrices pour la description
normalisée des essais immunologiques et des essais récepteur pour la
détection des résidus antimicrobiens
Reference numbers
ISO 18330:2003(E)
IDF 188:2003(E)
©
ISO and IDF 2003
---------------------- Page: 1 ----------------------
ISO 18330:2003(E)
IDF 188:2003(E)
PDF disclaimer
This PDF file may contain embedded typefaces. In accordance with Adobe's licensing policy, this file may be printed or viewed but
shall not be edited unless the typefaces which are embedded are licensed to and installed on the computer performing the editing. In
downloading this file, parties accept therein the responsibility of not infringing Adobe's licensing policy. Neither the ISO Central
Secretariat nor the IDF accepts any liability in this area.
Adobe is a trademark of Adobe Systems Incorporated.
Details of the software products used to create this PDF file can be found in the General Info relative to the file; the PDF-creation
parameters were optimized for printing. Every care has been taken to ensure that the file is suitable for use by ISO member bodies
and IDF national committees. In the unlikely event that a problem relating to it is found, please inform the ISO Central Secretariat at the
address given below.
© ISO and IDF 2003
All rights reserved. Unless otherwise specified, no part of this publication may be reproduced or utilized in any form or by any means,
electronic or mechanical, including photocopying and microfilm, without permission in writing from either ISO or IDF at the respective
address below.
ISO copyright office International Dairy Federation
Case postale 56 • CH-1211 Geneva 20 Diamant Building • Boulevard Auguste Reyers 80 • B-1030 Brussels
Tel. + 41 22 749 01 11 Tel. + 32 2 733 98 88
Fax + 41 22 749 09 47 Fax + 32 2 733 04 13
E-mail copyright@iso.org E-mail info@fil-idf.org
Web www.iso.org Web www.fil-idf.org
Published in Switzerland
ii © ISO and IDF 2003 — All rights reserved
---------------------- Page: 2 ----------------------
ISO 18330:2003(E)
IDF 188:2003(E)
Foreword
ISO (the International Organization for Standardization) is a worldwide federation of national standards
bodies (ISO member bodies). The work of preparing International Standards is normally carried out through
ISO technical committees. Each member body interested in a subject for which a technical committee has
been established has the right to be represented on that committee. International organizations, governmental
and non-governmental, in liaison with ISO, also take part in the work. ISO collaborates closely with the
International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization.
International Standards are drafted in accordance with the rules given in the ISO/IEC Directives, Part 2.
The main task of technical committees is to prepare International Standards. Draft International Standards
adopted by the technical committees are circulated to the member bodies for voting. Publication as an
International Standard requires approval by at least 75 % of the member bodies casting a vote.
Attention is drawn to the possibility that some of the elements of this document may be the subject of patent
rights. ISO shall not be held responsible for identifying any or all such patent rights.
ISO 18330IDF 188 was prepared by Technical Committee ISO/TC 34, Food products, Subcommittee SC 5,
Milk and milk products, and the International Dairy Federation (IDF), in collaboration with AOAC International.
It is being published jointly by ISO and IDF and separately by AOAC International.
© ISO 2003 — All rights reserved iii
---------------------- Page: 3 ----------------------
ISO 18330:2003(E)
IDF 188:2003(E)
Foreword
IDF (the International Dairy Federation) is a worldwide federation of the dairy sector with a National
Committee in every member country. Every National Committee has the right to be represented on the IDF
Standing Committees carrying out the technical work. IDF collaborates with ISO and AOAC International in
the development of standard methods of analysis and sampling for milk and milk products.
Draft International Standards adopted by the Action Teams and Standing Committees are circulated to the
National Committees for voting. Publication as an International Standard requires approval by at least 50 % of
the National Committees casting a vote.
ISO 18830IDF 188 was prepared by Technical Committee ISO/TC 34, Food products, Subcommittee SC 5,
Milk and milk products, and the International Dairy Federation (IDF), in collaboration with AOAC International.
It is being published jointly by ISO and IDF and separately by AOAC International.
All work was carried out by the Joint ISO/IDF/AOAC Action Team Antimicrobials and other veterinary medical
residues, of the Standing Committee Analytical methods for additives and contaminants, under the aegis of its
project leader, Mr E. Märtlbauer (DE)
iv © ISO 2003 — All rights reserved
---------------------- Page: 4 ----------------------
ISO 18330:2003(E)
IDF 188:2003(E)
Introduction
Because of the method of detection, the tests described in this International Standard may have limitations so
that they cannot be used for quantification. For example, receptor assays have group-specific detection and
not chemical-specific detection. Consequently, positive results cannot be subject to quantitation without
knowledge of the identity of the specific contaminant. Moreover, assays based on a visual evaluation of colour
development may not measure the degree of colour and thus may not provide a quantitative value.
Within an integrated system for antimicrobial residue detection, immunoassays and receptor assays may be
used as primary-screening methods (e.g. for screening of compounds which can not be detected at regulatory
levels by microbiological inhibition assays). These methods may also be used as post-screening methods for
preliminary identification and quantification of compounds in samples with a positive result in a microbiological
inhibition assay.
Depending on whether a certain test complies with the specifications given, immunoassays and receptor
assays may be used for routine quality control, especially if the absence/presence of a certain compound in
concentrations exceeding a certain level [e.g. maximum residue limit (MRL)] has to be determined.
Substances which are not approved or for which no MRLs have been fixed, may require specific consideration.
For legal purposes in many countries, positive results obtained by immunoassays or receptor assays require
confirmation by an accepted physico-chemical method.
© ISO 2003 — All rights reserved v
---------------------- Page: 5 ----------------------
ISO 18330:2003(E)
INTERNATIONAL STANDARD
IDF 188:2003(E)
Milk and milk products — Guidelines for the standardized
description of immunoassays or receptor assays for the
detection of antimicrobial residues
1 Scope
This International Standard gives guidelines for the standardized description of immunoassays or receptor
assays for the detection of antimicrobial residues in milk and milk products.
It is intended to provide a framework and basis for the evaluation/validation of tests based on the binding of an
antimicrobial compound to its specific antibody or to other types of detecting molecules.
In addition to immunoassays [e.g. enzyme-immunoassay (EIA) and radio-immunoassay (RIA)], there are
several quantitative, semi-quantitative and qualitative test formats based on the binding of antimicrobial
compounds to microbial receptors or to receptor proteins. Enzymatic assays and particle-based assays based
on receptor proteins are referred to as receptor assays in this International Standard.
2 Normative references
The following referenced documents are indispensable for the application of this document. For dated
references, only the edition cited applies. For undated references, the latest edition of the referenced
document (including any amendments) applies.
ISO 13969, Milk and milk products — Guidance for a standardized description of microbial inhibitor tests
3 Terms and definitions
For the purposes of this document, the following terms and definitions apply.
3.1
false positives
percentage of positive results when testing negative samples
3.2
false negatives
percentage of negative results at the claimed detection level(s)
3.3
specificity
extent to which the presence of substances with chemical structures similar to that of the target analyte will
result in a positive result (cross-reaction)
3.4
limit of detection for qualitative tests
concentration level at which a defined percentage of samples is detected, e.g. 95 % together with the
respective confidence level.
© ISO and IDF 2003 — All rights reserved 1
---------------------- Page: 6 ----------------------
ISO 18330:2003(E)
IDF 188:2003(E)
3.5
limit of detection for quantitative tests
concentration level which gives a final result that is statistically different from that of negative milk
4 Information needed from the developer/manufacturer
4.1 Methodology
The developer or manufacturer of the test should provide information regarding methodology by mentioning
the following:
a) description of the method (e.g. sample preparation and test performance);
b) principle of the method (e.g. competitive direct enzyme-immunoassay);
c) evaluation of test results (e.g. visual or instrumental reading, criteria for positive or negative result);
d) capacity (e.g. sample throughput);
e) special requirements for sampling, preservation and testing;
f) procedure for the purpose of quality assurance, including the use of positive/negative control samples;
g) field of application concerning
the intended test use [e.g. screening for milk quality payment or for regulatory purposes (detection of
banned substances)],
the substrate or matrix (e.g. raw tanker bulk milk or heat-treated milk), and
the limitations with respect to sample composition (e.g. cell count and bacteriological quality).
4.2 Test kit reagents
The following information should be given regarding test kit reagents.
a) In the case of immunoassays:
1) type of antibodies (e.g. monoclonal or polyclonal, sheep, rabbit or egg);
2) type of antigen used in the test (e.g. antigen-enzyme conjugate, solid-phase antigen);
3) type of marker for signal production (e.g. enzyme: peroxidase, alkaline phosphatase; radiochemical:
3 14 125
H , C , I ; inert bead: colour latex bead, gold);
4) type of enzyme substrate and type of substance used for transformation of enzyme activity to
measured signal (e.g. hydrogen peroxide/tetramethylbenzidine), if applicable.
b) In the case of microbial receptor assays:
1) type of label (e.g. radioactive isotope),
2) amount of radioactivity and safety requirements, and
3) type of receptor (e.g. non-viable microbial cells or antibody).
2 © ISO and IDF 2003 — All rights reserved
---------------------- Page: 7 ----------------------
ISO 18330:2003(E)
IDF 188:2003(E)
c) In the case of receptor protein assays:
1) type of receptor protein used (e.g. enzyme-receptor conjugate),
2) type of reagent competing for receptor protein binding sites (e.g. analyte-enzyme conjugate, solid-
phase analyte),
3) type of enzyme substrate and type of substance used for transformation of enzyme activity to
measured signal, and
4) enzymatic reaction(s) used to produce signal.
4.3 Additional chemicals not necessarily included in the test kit
The following should be mentioned regarding additional chemicals not necessarily included in the test kit:
a) purity and quality of chemicals required;
b) composition and preparation of solutions;
c) storage conditions and stability of solutions;
d) water quality required.
4.4 Operating requirements
The following information should be given regarding operating requirements:
a) requirements for user experience and training;
b) requirements for laboratory equipment:
1) microtitre plate reader,
2) fluorometer, scintillation counter, computer hard- and software,
3) incubators and precision pipettes;
c) requirements for safety (e.g. for handling and disposal of radioactive waste);
d) requirements for quality control by developer/manufacturer and/or user.
4.5 Test specifications
The following information should be given regarding test definitions:
a) false positives: see 3.1;
b) false negatives: see 3.2;
c) specificity: see 3.3;
d) limit of detection: see 3.4 and 3.5 respectively;
e) precision: figures for repeatability and reproducibility obtained from the results of collaborative studies, if
carried out and available.
© ISO and IDF 2003 — All rights reserved 3
---------------------- Page: 8 ----------------------
ISO 18330:2003(E)
IDF 188:2003(E)
4.6 Documentation
The following information should be given regarding documentation:
a) user manual, including a trouble-shooting guide;
b) suppliers of instruments, reagents, standards, technical services and customer support;
c) status of official recognition in specified countries (if available);
d) availability of reference material;
e) availability of internationally recognized and/or validated references from ISO, IDF and AOAC
International or others;
f) availability of, for example, literature and practical experiences.
5 Evaluation of the attributes of the enzyme-immuno or receptor assay
5.1 Prerequisites (see ISO 13969)
5.1.1 Milk free from antimicrobials (“negative milk”)
The cows from which milk is collected in order to serve as “negative milk” shall meet the following
requirements. If, however, a test is applied for milk of an animal species other than cows, the requirements
with respect to the status of that animal should be adjusted accordingly.
a) The clinical and sub-clinical health status shall be good, with special emphasis on udder health (less than
150 000 somatic cells per millilitre).
b) The treatment or feeding with antimicrobial substances shall be prohibited for at least 8 weeks before milk
collection. In the case of dry cow treatment, the milk shall not be collected earlier than 60 days after
calving provided the dry cow period was at least 4 weeks.
c) The cows shall be mid-lactation: more than 60 days and less than 200 days after calving, producing more
than 5 kg milk per day.
d) The milking of at least five to seven cows shall be combined to overcome individual variations in milk
composition.
4
e) The total viable count shall be less than 10 colony-forming units (CFU) per millilitre before the
preservation process (deep-freezing, lyophilisation). The possible presence of b-lactamase-producing
microorganisms shall be kept in mind in the case of b-lactam antibiotic testing.
5.1.2 Test substances
The test substances which are used in the testing procedure should be obtained from a recognized
developer/manufacturer, preferably with an analytical certificate with a guaranteed specification. The
concentration required should be calculated based on the free acid or base forms of the drug corrected for
purity. Special considerations should be given to substances with stability/potency problems.
Unless otherwise stated, it is preferable that the evaluation of detection limits (5.2.2) should be undertaken
using those antimicrobials and/or concentrations that the developer/manufacturer claims the test will detect.
4 © ISO and IDF 2003 — All rights reserved
---------------------- Page: 9 ----------------------
ISO 18330:2003(E)
IDF 188:2003(E)
5.1.3 Solvents
If special solvents or other chemicals are required to dissolve the substances, it should have been ensured
that these solvents or chemicals in the test samples have no influence on the test result.
5.1.4 Preparation of test samples
5.1.4.1 General
For large-scale evaluations (e.g. to obtain the data basis for a generalized description), all dilutions required
should have been prepared in one batch to avoid day-to-day variations in weighing, diluting and differences in
the status of the “negative milk”.
The preparation of test samples may cause problems and is a very laborious task for the test evaluation
laboratories. Therefore, it might be appropriate to employ a centralized test sample preparation laboratory
which agrees to supply interested laboratories with the test samples in stable form (e.g. lyophilized).
5.1.4.2 Selection of concentrations
The selection of concentrations for the determination of the detection limits is described in 5.2.2. For
estimated purposes, if not otherwise stated, the concentration found to represent the detection limit should be
tested together with one concentration level higher and two or three concentration steps lower than the
claimed detection limit and the corresponding negative milk. These data may be used to estimate the 25 %,
50 %, 75 % and 95 % positive sample concentration. As an approximate guideline, it is recommended to
divide the concentration range resulting in 50 % to 100 % positive samples into three or four equally distant
levels (linear and logarithmic scales respectively) as demonstrated in Figure 1.
5.1.4.3 Dilution
The following precautions should be met when preparing dilution series of test substances.
a) The preparation of the dilution series should be carried out in such a way that only the final dilution step is
prepared with milk in order to avoid protein binding.
b) The proportion of the added aqueous standard solution in the final milk dilution step should be the same
for all test samples and less than 1 %.
5.1.4.4 Preservation
Preservation of test samples should preferably be done by lyophilization, if this is not deprecated by the
developer/manufacturer of the test under study or the test princip
...
Questions, Comments and Discussion
Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.